Introduction: Impaired physical fitness is a possible late effect among adult survivors of childhood cancer (ASCC). Our study describes lower body muscular strength and endurance among ASCC using the 1-minute sit-to-stand (1-min STS) test, compares them with the general population, identifies risk factors, and describes changes over time.Methods: In a prospective multicenter cohort study, we invited ASCC ≥18 years of age at study, diagnosed between ages 0-20 treated in five pediatric oncology centers across Switzerland from 1976-2017 who survived ≥5 years for a 1-min STS test. We collected information about lifestyle, medical history, and previous cancer treatment. Using population-based Swiss reference values, we calculated age- and sex-adjusted z-scores for 1-min STS performance and assessed the association between risk factors and 1-min STS test using multivariable linear regression. We fitted a multilevel linear model to describe the longitudinal course of 1-min STS performance.Results: We included 338 CCS of 1048 invited ASCC (participation rate 32%) with median age at study of 34 years (interquartile range 26-41). Compared with the general population, mean 1-min STS z-score was half a standard deviation lower (-0.52; 95% CI -0.64 to -0.40). Obesity (B = -0.56; 95% CI -0.97 to -0.16), cumulative cisplatin dose (B = -0.12; 95% CI -0.21 to -0.02), and cumulative cranial radiotherapy dose (B = -0.10; 95% CI -0.19 to -0.01) were associated with reduced 1-min STS performance. There was no change in 1-min STS z-scores over time (B = 0.02; 95% CI -0.05 to 0.09).Conclusions : We found evidence for reduced lower body strength and endurance among ASCC, suggesting the need for counseling and effective training and rehabilitation programs for maintaining daily functioning, improving cardiovascular health, and reducing morbidity for ASCC.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1249/MSS.0000000000003593 | DOI Listing |
Med Sci Sports Exerc
November 2024
Division of Pediatric Oncology/Hematology, University Children's Hospital Basel, University of Basel, Basel, SWITZERLAND.
Introduction: Impaired physical fitness is a possible late effect among adult survivors of childhood cancer (ASCC). Our study describes lower body muscular strength and endurance among ASCC using the 1-minute sit-to-stand (1-min STS) test, compares them with the general population, identifies risk factors, and describes changes over time.Methods: In a prospective multicenter cohort study, we invited ASCC ≥18 years of age at study, diagnosed between ages 0-20 treated in five pediatric oncology centers across Switzerland from 1976-2017 who survived ≥5 years for a 1-min STS test.
View Article and Find Full Text PDFAnn Rehabil Med
December 2024
Department of Traditional Chinese Medicine, School of Public Health, University of Phayao, Phayao, Thailand.
Objective: To evaluate muscle strength and cardiorespiratory parameters, this study uses simple tests in older adults, including those who have and have not recovered from mild coronavirus disease 2019 (COVID-19).
Methods: Eighty older adults (age≥60 years old) were divided into two groups: those without previous COVID-19 (control group, n=40) and those with recovery from mild COVID-19 (recovered group, n=40). Muscle strength was assessed using a handgrip strength test and the sit-to-stand test (STS10).
Background And Objective: There is a need for simple functional test to assess treatment response in chronic pulmonary aspergillosis (CPA) in resource-constrained settings. The one-minute-sit-to-stand test (1-min-STS) is one such test. However, the minimal important difference (MID) for 1-min-STS in subjects with CPA remains unknown.
View Article and Find Full Text PDFAntibiotics (Basel)
July 2024
Department of Microbiology, School of Medicine, Kyungpook National University, Daegu 37224, Republic of Korea.
J Clin Med
June 2024
Hypertension and Cardiovascular Risk Factors Research Centre, Medical and Surgical Sciences Department, Alma Mater Studiorum University of Bologna, 40138 Bologna, Italy.
Available evidence from randomized clinical trials is contrasting and definitely inconclusive in determining whether or not CoQ dietary supplementation is advisable in patients with statin intolerance or poor statin tolerability. This randomized, double-blind, placebo-controlled clinical study aimed at investigating the effect of chronic dietary supplementation with coenzyme Q (CoQ) phytosome on physical performance in older adults with a ≥3-month history of statin-associated asthenia. The study's participants were randomized to either a placebo or 300 mg daily CoQ phytosome (equivalent to 60 mg CoQ; Ubiqsome, Indena SpA, Milan, Italy).
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!